Review ArticleReviews

Headache Reporting in Oncology Trials Depends on the Demographics of the Study Population

BIRTE J. WOLFF, MATTHAEUS J. WOLFF and JOHANNES E. WOLFF
In Vivo July 2021, 35 (4) 1939-1943; DOI: https://doi.org/10.21873/invivo.12460

Article Information

vol. 35 no. 4 1939-1943
DOI 
https://doi.org/10.21873/invivo.12460
PubMed 
34182466
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received March 20, 2021
  • Revision received April 20, 2021
  • Accepted April 26, 2021
  • Published online June 21, 2021.
Copyright & Usage 
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. BIRTE J. WOLFF1,
  2. MATTHAEUS J. WOLFF2 and
  3. JOHANNES E. WOLFF3⇑
  1. 1Swedish Covenant Hospital Department of Gynecology, Chicago, IL, U.S.A.;
  2. 2Bellevue, WA, U.S.A.;
  3. 3Wauconda, IL, U.S.A.
  1. Correspondence to: Dr. Med habil Johannes E. Wolff, MD, Ph.D., 1709 Napa Suwe Ln, Wauconda, IL 60084, U.S.A. E-mail: johannesewolff{at}gmail.com
View Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Headache Reporting in Oncology Trials Depends on the Demographics of the Study Population
BIRTE J. WOLFF, MATTHAEUS J. WOLFF, JOHANNES E. WOLFF
In Vivo Jul 2021, 35 (4) 1939-1943; DOI: 10.21873/invivo.12460
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords